UC Davis awarded new CRISPR grant to test novel approach to cancer treatment

UC Davis researchers have been awarded $1.5 million from the National Institutes of Health (NIH) for the first part of a project to develop a novel approach to deliver genome editing machinery to genes responsible for a rare form of familial cancer. [Read More]